Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Research Partnership ranks 13th in the top 20 fastest-growing agencies in the UK

February 4, 2019 | Pharma, healthcare, market research 

The UK’s best performing market research agencies were revealed earlier this month with the publication of Research Live’s Industry Report for 2019, which includes the latest Market Research Society (MRS) League Tables. Based on 2017 financial data that was compiled and analysed in November 2018, the MRS league tables identify and rank the best-performing research agencies and businesses according to their UK-based turnover and by their year-on-year growth.

With a growth rate of 21.87%, Research Partnership has been ranked 13th in the top 20 fastest-growing individual agencies. In addition, with over £27.5 million in sales, the company ranked 25th in the top 50 consolidated businesses, which draws agencies together under ownership groups, and 27th in the top 100 individual agencies, both of which are ranked by annual turnover.

Founding Director Mark Jeffery was interviewed for the report’s ‘Perspective from the Fastest Growers’ to find out how Research Partnership is achieving growth in an uncertain climate. Mark commented, “We are delighted to see Research Partnership placed so well in the league tables again this year. Our senior level and business development teams work hard to secure new clients, and our research teams ensure that we receive repeat business by delivering the very best service. We celebrated our 20th anniversary last year and have enjoyed consistent growth every year since we started. As a result we are now the largest independent healthcare market research agency in the world, working with all the major global pharma organisations.”

In the past year Research Partnership’s has also expanded into the medical technology space, built up the company’s market access capabilities, opened three new offices across the US and Europe, and grown the workforce by 15%.

Read the full report here »

This content was provided by Research Partnership

Company Details

- PMLiVE

Research Partnership

Email
Website

 Latest Content from  Research Partnership 

New syndicated report – Living with Ulcerative Colitis 2024

Living with Ulcerative Colitis (UC) is a new syndicated patient report that presents valuable insights into the unmet needs and the burden experienced by patients living with UC. The report...

Webcast: AI in MRX: Harnessing the power of AI + people

Artificial intelligence (AI) in market research has surged in recent years, with a flow of innovative tools and techniques which have the potential to revolutionize the landscape. But to unlock...

Navigating challenges of MedTech research with rare-disease patients

Authored by: Tom Donnelly, MedTech Director and Amanda Pirraglia, Associate Director. Published in Quirk's Magazine.

Product launch: What market research when?

Get the insights you need, when you need them, for your product launch planning

Therapy Watch launches new tracker covering Alzheimer’s Disease

The new Therapy Watch Alzheimer’s Disease tracker has recently launched in Germany, Japan and the US, with planned expansion into the remaining key European markets throughout 2024.

Therapy Watch launches new tracker covering pulmonary arterial hypertension (PAH)

Therapy Watch Pulmonary Arterial Hypertension (PAH) is launching in the US market, with expansion into other geographies including Europe in 2024.

Healthcare in the age of AI: How will artificial intelligence impact future decision-making?

Authored by: Constanza Salas, Jhon Galindo and Rachel Howard

Therapy Watch launches new tracker covering Postpartum Depression

The new Therapy Watch Postpartum depression (PPD) study is the first tracker in the series to cover Psychiatry

Value-based pricing reform: Strengthening the ‘front door’ to the Colombian pharmaceutical market

Authored by: Marc Garcia and Tania Rodrigues

Infographic: Rare Diseases in China

How rare are rare diseases in China? Download this infographic to find out more and how we can offer guidance for pharma companies to consider.